Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study.
Conclusions: PIO did not promote malignant alterations of NUTE cells or stimulate proliferation of J82 cells. PIO decreased the expression of p53 and cyclin D1 in J82 cells after long-term culture, which suggested that PIO may be helpful for diabetic patients with bladder cancer.
PMID: 29483814 [PubMed - in process]
Source: International Journal of Medical Sciences - Category: Biomedical Science Tags: Int J Med Sci Source Type: research
More News: Actos | Biomedical Science | Bladder Cancer | Cancer | Cancer & Oncology | Diabetes | Endocrinology | Study | Transitional Cell Carcinoma